Cargando…

Cost Analysis and Outcomes of Endoscopic, Minimal Access and Open Pancreatic Necrosectomy

OBJECTIVES: To assess both individual patient and institutional costs as well as outcomes in patients with pancreatic necrosis who underwent either endoscopic, minimal access or open pancreatic necrosectomy. These data can be used to evaluate clinical effectiveness with a view to informing local hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Saunders, Rebecca, Hughes, Faye E., Evans, Jonathan C., Smart, Howard L., Ghaneh, Paula, Ramesh, Jayapal, Sutton, Robert, Halloran, Christopher M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610877/
https://www.ncbi.nlm.nih.gov/pubmed/34079959
http://dx.doi.org/10.1097/AS9.0000000000000068
_version_ 1783605239794892800
author Saunders, Rebecca
Hughes, Faye E.
Evans, Jonathan C.
Smart, Howard L.
Ghaneh, Paula
Ramesh, Jayapal
Sutton, Robert
Halloran, Christopher M.
author_facet Saunders, Rebecca
Hughes, Faye E.
Evans, Jonathan C.
Smart, Howard L.
Ghaneh, Paula
Ramesh, Jayapal
Sutton, Robert
Halloran, Christopher M.
author_sort Saunders, Rebecca
collection PubMed
description OBJECTIVES: To assess both individual patient and institutional costs as well as outcomes in patients with pancreatic necrosis who underwent either endoscopic, minimal access or open pancreatic necrosectomy. These data can be used to evaluate clinical effectiveness with a view to informing local healthcare providers. BACKGROUND: Intervention for infected pancreatic necrosis is associated with a high morbidity, mortality, and long hospital stays. Minimal access surgical step-up approaches have been the gold standard of care; however, endoscopic approaches are now offered preferentially. METHODS: All patients undergoing endoscopic (EN), minimal access retroperitoneal (MARPN), and open (OPN) necrosectomy at a single institution from April 2015 to March 2017 were included. Patients were selected for intervention based on morphology and position of the necrosis and on clinical factors. Patient-level costing systems were used to determine inpatient and outpatient costs. RESULTS: Eighty-six patients were included: 38 underwent EN, 35 MARPN, and 13 OPN. Preoperative APACHEII was 6 versus 9 versus 9 (P = 0.017) and CRP 107 versus 204 versus 278 (P = 0.012), respectively. Postoperative stay was 19 days for EN versus 41 for MARPN versus 42 for OPN (P = 0.007). Complications occurred in 68.4%, 68.6%, and 46.2% (P = 0.298), whereas mortality was 10.5%, 22.9%, and 15.4% (P = 0.379), respectively. Mean total cost was £31,364 for EN, £52,770 for MARPN (P = 0.008), and £60,346 for OPN. Ward and critical care costs for EN were lower than for MARPN (ward: £9430 vs £14,033, P = 0.024; critical care: £5317 vs £16,648, P = 0.056). CONCLUSIONS: EN was at least as safe and effective as MARPN and OPN and was associated with markedly reduced hospital stay and cost, although some markers of disease severity were higher in patients undergoing MARPN and OPN. These results support EN as the preferred approach to necrosectomy, but hybrid utilization of all available techniques remains integral to optimal outcomes.
format Online
Article
Text
id pubmed-7610877
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer Health, Inc.
record_format MEDLINE/PubMed
spelling pubmed-76108772021-06-01 Cost Analysis and Outcomes of Endoscopic, Minimal Access and Open Pancreatic Necrosectomy Saunders, Rebecca Hughes, Faye E. Evans, Jonathan C. Smart, Howard L. Ghaneh, Paula Ramesh, Jayapal Sutton, Robert Halloran, Christopher M. Ann Surg Open Original Study OBJECTIVES: To assess both individual patient and institutional costs as well as outcomes in patients with pancreatic necrosis who underwent either endoscopic, minimal access or open pancreatic necrosectomy. These data can be used to evaluate clinical effectiveness with a view to informing local healthcare providers. BACKGROUND: Intervention for infected pancreatic necrosis is associated with a high morbidity, mortality, and long hospital stays. Minimal access surgical step-up approaches have been the gold standard of care; however, endoscopic approaches are now offered preferentially. METHODS: All patients undergoing endoscopic (EN), minimal access retroperitoneal (MARPN), and open (OPN) necrosectomy at a single institution from April 2015 to March 2017 were included. Patients were selected for intervention based on morphology and position of the necrosis and on clinical factors. Patient-level costing systems were used to determine inpatient and outpatient costs. RESULTS: Eighty-six patients were included: 38 underwent EN, 35 MARPN, and 13 OPN. Preoperative APACHEII was 6 versus 9 versus 9 (P = 0.017) and CRP 107 versus 204 versus 278 (P = 0.012), respectively. Postoperative stay was 19 days for EN versus 41 for MARPN versus 42 for OPN (P = 0.007). Complications occurred in 68.4%, 68.6%, and 46.2% (P = 0.298), whereas mortality was 10.5%, 22.9%, and 15.4% (P = 0.379), respectively. Mean total cost was £31,364 for EN, £52,770 for MARPN (P = 0.008), and £60,346 for OPN. Ward and critical care costs for EN were lower than for MARPN (ward: £9430 vs £14,033, P = 0.024; critical care: £5317 vs £16,648, P = 0.056). CONCLUSIONS: EN was at least as safe and effective as MARPN and OPN and was associated with markedly reduced hospital stay and cost, although some markers of disease severity were higher in patients undergoing MARPN and OPN. These results support EN as the preferred approach to necrosectomy, but hybrid utilization of all available techniques remains integral to optimal outcomes. Wolters Kluwer Health, Inc. 2021-05-07 /pmc/articles/PMC7610877/ /pubmed/34079959 http://dx.doi.org/10.1097/AS9.0000000000000068 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Study
Saunders, Rebecca
Hughes, Faye E.
Evans, Jonathan C.
Smart, Howard L.
Ghaneh, Paula
Ramesh, Jayapal
Sutton, Robert
Halloran, Christopher M.
Cost Analysis and Outcomes of Endoscopic, Minimal Access and Open Pancreatic Necrosectomy
title Cost Analysis and Outcomes of Endoscopic, Minimal Access and Open Pancreatic Necrosectomy
title_full Cost Analysis and Outcomes of Endoscopic, Minimal Access and Open Pancreatic Necrosectomy
title_fullStr Cost Analysis and Outcomes of Endoscopic, Minimal Access and Open Pancreatic Necrosectomy
title_full_unstemmed Cost Analysis and Outcomes of Endoscopic, Minimal Access and Open Pancreatic Necrosectomy
title_short Cost Analysis and Outcomes of Endoscopic, Minimal Access and Open Pancreatic Necrosectomy
title_sort cost analysis and outcomes of endoscopic, minimal access and open pancreatic necrosectomy
topic Original Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610877/
https://www.ncbi.nlm.nih.gov/pubmed/34079959
http://dx.doi.org/10.1097/AS9.0000000000000068
work_keys_str_mv AT saundersrebecca costanalysisandoutcomesofendoscopicminimalaccessandopenpancreaticnecrosectomy
AT hughesfayee costanalysisandoutcomesofendoscopicminimalaccessandopenpancreaticnecrosectomy
AT evansjonathanc costanalysisandoutcomesofendoscopicminimalaccessandopenpancreaticnecrosectomy
AT smarthowardl costanalysisandoutcomesofendoscopicminimalaccessandopenpancreaticnecrosectomy
AT ghanehpaula costanalysisandoutcomesofendoscopicminimalaccessandopenpancreaticnecrosectomy
AT rameshjayapal costanalysisandoutcomesofendoscopicminimalaccessandopenpancreaticnecrosectomy
AT suttonrobert costanalysisandoutcomesofendoscopicminimalaccessandopenpancreaticnecrosectomy
AT halloranchristopherm costanalysisandoutcomesofendoscopicminimalaccessandopenpancreaticnecrosectomy